1997 Wylie Scholar
Chief, Division of Vascular Surgery
University of Utah

Larry Kraiss, MD is investigating a new treatment for patients with kidney disease who need dialysis and is involved in a clinical trial of a drug that may reduce the rate of aneurysm growth.

As a Wylie Scholar, Dr. Kraiss studied how endothelial cells that line the blood vessels respond to changes in their environment including blood clots, inflammation, and changes in blood flow. He identified the triggers of abnormal cell growth due to vascular disease and laid the groundwork for new drug treatments and innovative therapies.

Dr. Kraiss runs a basic biology laboratory focused on endothelial cell biology and is Chief of the Division of Vascular Surgery at the University of Utah. Learn more about Larry Kraiss, MD...